The ageing (geriatric) population worldwide is another factor boosting the growth of the global infusion pump market. For instance, the demand for infusion pumps and therapies rises as a result of the increasing risk of chronic and long-term health issues among the geriatric population. The World Health Organisation (WHO) predicts that by 2030, 1 in 6 people will be 60 or older, and that by 2050, the number of individuals 60 and older would have doubled (to 2.1 billion). Consequently, as the elderly population grows, so does the demand for infusion pumps.
The market for Infusion Pumps was estimated at US$ 8.87 billion in 2022 and is anticipated to grow at a CAGR of 8.4% from 2023 to 2030 to reach US$ 16.91 billion.
Key Companies in the Infusion Pumps Industry:
1. BD: creator of an analytical flow cytometer intended to advance medical research, diagnosis, and treatment. The company's technology helps improve the security and effectiveness of clinicians' care delivery, allowing researchers to more thoroughly examine cells to comprehend health and disease. Created in 2004. United States headquarters. A new leader in the health care sector with an estimated $16 billion in annualised revenue has been established thanks to the acquisition of C. R. Bard, Inc. by BD, a prominent global provider of medical technology.
2. Fresenius Kabi: Owner of a healthcare organisation that will supply biosimilar medications with an emphasis on oncology and autoimmune illnesses. The business specialises in complex biopharmaceuticals, critical care medications, generic drugs administered intravenously, and infusion, transfusion, and clinical nutrition technology. created in 1999. Headquarters in Germany's Homburg. To strengthen its Kabi pharmaceuticals unit, Fresenius agrees to two purchases.
3. ICU Medical: Creator of a transient pacemaker intended to improve cardiac stimulation by lowering procedure-related risks. The company's pacemaker uses technology to develop a permanent pacemaker to perform temporary cardiac pacing with fewer issues and compatibility, allowing medical practitioners to shorten cardiac patients' stays in the intensive care unit (ICU). 2020 saw the founding. Head office in Spain.
4. Smith’s Medical: Medical device producer situated in Minneapolis, Minnesota. Anaesthesia breathing circuits, masks, endotracheal tubes, laryngeal masks, replacement catheters for embryos, insulin technology systems, drainage systems, infusion disposable systems, interventional imaging, pressure monitoring systems, sharps safety devices, fast flow fluid warmers, peripheral I.V. catheters, and transport ventilators are all products offered by the business. Established in 1940. United States headquarters.ICU Medical declared in January 2022 that it has finished buying the Smiths Medical Division from Smiths Group Plc.
5. Medtronic: Developer of medical technologies for treating chronic conditions. People with persistent pain have lifelong remedies thanks to the company's medical technologies. Founded in 1940. United States headquarters. Boston Scientific withdraws from an acquisition, Medtronic makes a nearly $740 million purchase.
6. B. Braun Melsungen: Manufacturer of medical equipment and supplies committed to preserving and enhancing public health. For anaesthesia, intensive care, cardiology, extracorporeal blood therapy, and operations, the company provides products and product systems, empowering medical staff and patients to make the best choices possible. Established in 1838. Headquarters in Germany's Melsungen. Lauer (Jun 2015), Dialy (Feb 2014), and Ahlcon Parenterals (Mar 2012) are the most recent acquisitions.
*Definition: An infusion pump is a medical device used to deliver fluids, such as nutrients and medications, into a patient's body in controlled amounts.
